STAT+: The end for GSK’s chronic cough treatment

STAT PlusNewsletterThe Readout The end for GSK’s chronic cough treatment Sonothera’s ultrasound gene therapy delivery, a new Alzheimer’s drug controversy, and more biotech news from The Readout Manage alerts for this article Email this article Share this article By Meghana KeshavanJuly 17, 2026 Biotech Correspondent Meghana Keshavan[email protected]Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hiya. Today, we explore a gene therapy approach that’s drawing excitement but also skepticism, and see that Jennifer Doudna is moving into AI-designed gene editors that push beyond evolution. Advertisement Plus, our trusty podcasters unpack the buzzy prediction market Kalshi’s move into biotech. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In biotechnology, drug development, Drug prices, research Submit a correction requestReprints Meghana Keshavan Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter. Newsletter Your morning rundown of the science, politics, and money driving biotech today Recommended Biotech July 17, 2026 STAT Plus: Can ultrasound unlock the power of gene therapy? A startup makes big claims The Readout July 16, 2026 STAT Plus: FDA approves Merck’s oral PCSK9 drug, a first Advertisement Pharma July 16, 2026 STAT Plus: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals Biotech July 16, 2026 STAT Plus: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley Adam's Biotech Scorecard July 16, 2026 STAT Plus: Amylyx nears pivotal endocrine drug study readout Subscriber Picks